ANI Pharmaceuticals
ANIP
#4819
Rank
$1.83 B
Marketcap
$81.77
Share price
-1.17%
Change (1 day)
43.53%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total debt

Total debt on the balance sheet as of September 2025 : $0.62 Billion USD

According to ANI Pharmaceuticals's latest financial reports the company's total debt is $0.62 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

ANI Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$0.62 B118.47%
2023-12-31$0.28 B-0.3%
2022-12-31$0.28 B-0.3%
2021-12-31$0.28 B54.76%
2020-12-31$0.18 B-0.03%
2019-12-31$0.18 B1.49%
2018-12-31$0.18 B-9.18%
2017-12-31$0.20 B67.03%
2016-12-31$0.12 B6.36%
2015-12-31$0.11 B6.46%
2014-12-31$0.10 B
2013-12-31N/A-100%
2012-12-31$7.88 M-54.53%
2011-12-31$17.33 M-6.53%
2010-12-31$18.54 M11.22%
2009-12-31$16.67 M
2000-12-31$0.5 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Jazz Pharmaceuticals
JAZZ
$5.42 B 775.13%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
$5.12 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$17.07 B 2,652.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
$60.84 B 9,709.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
$0.63 B 3.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$2.62 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
$9.03 B 1,356.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$32.02 B 5,062.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
$8.94 B 1,342.14%๐Ÿ‡ฌ๐Ÿ‡ง UK